Cargando…

Cholesterol-Induced Non-Alcoholic Fatty Liver Disease and Atherosclerosis Aggravated by Systemic Inflammation

Although triglyceride accumulation in the liver causes non-alcoholic fatty liver disease (NAFLD), hypercholesterolemia is also a main cause of NAFLD as well as atherosclerosis. However, NAFLD and atherosclerosis have not been investigated simultaneously in animal models fed a high-cholesterol diet....

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Eung Ju, Kim, Baek-hui, Seo, Hong Seog, Lee, Yong Jik, Kim, Hyun Hee, Son, Hyun-Hwa, Choi, Man Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046981/
https://www.ncbi.nlm.nih.gov/pubmed/24901254
http://dx.doi.org/10.1371/journal.pone.0097841
_version_ 1782480341687074816
author Kim, Eung Ju
Kim, Baek-hui
Seo, Hong Seog
Lee, Yong Jik
Kim, Hyun Hee
Son, Hyun-Hwa
Choi, Man Ho
author_facet Kim, Eung Ju
Kim, Baek-hui
Seo, Hong Seog
Lee, Yong Jik
Kim, Hyun Hee
Son, Hyun-Hwa
Choi, Man Ho
author_sort Kim, Eung Ju
collection PubMed
description Although triglyceride accumulation in the liver causes non-alcoholic fatty liver disease (NAFLD), hypercholesterolemia is also a main cause of NAFLD as well as atherosclerosis. However, NAFLD and atherosclerosis have not been investigated simultaneously in animal models fed a high-cholesterol diet. Moreover, it is unclear whether systemic inflammation can exacerbate both pathologies in the same model. Accordingly, this study investigated the effect of additional systemic inflammation on NAFLD and atherosclerosis induced by cholesterol overload in wild animals. New Zealand white rabbits were divided into 4 groups: groups I (control) and II received normal chow, and groups III and IV received a 1% cholesterol diet. To induce inflammation via toll-like receptor (TLR)-4 signaling, groups II and IV received subcutaneous injections of 0.5 mL of 1% carrageenan every 3 weeks. After 3 months, total cholesterol markedly increased in groups III and IV, and the serum expressions of systemic inflammatory markers were elevated in the groups II–IV. Early NAFLD lesions (e.g., mild fatty changes in the liver with sporadic fibrosis) and atherosclerosis (e.g., intimal hyperplasia composed of foam cells) were observed in both the liver and aorta specimens from group III, and advanced lesions were observed in group IV. The expressions of inflammatory cellular receptors, TLR-2 and TLR-4, in the aorta gradually increased from group I to IV but were similar in the liver in groups II–IV. Cholesteryl ester (CE) levels were higher in group IV than in group III, although the difference was not significant. CE levels in the aorta were similar between groups III and IV. Systemic inflammation can simultaneously exacerbate existing early lesions due to cholesterol overload in both the liver and aorta of rabbits. However, the cellular response of inflammatory receptors and expression of cholesterol metabolites differ between these organs.
format Online
Article
Text
id pubmed-4046981
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40469812014-06-09 Cholesterol-Induced Non-Alcoholic Fatty Liver Disease and Atherosclerosis Aggravated by Systemic Inflammation Kim, Eung Ju Kim, Baek-hui Seo, Hong Seog Lee, Yong Jik Kim, Hyun Hee Son, Hyun-Hwa Choi, Man Ho PLoS One Research Article Although triglyceride accumulation in the liver causes non-alcoholic fatty liver disease (NAFLD), hypercholesterolemia is also a main cause of NAFLD as well as atherosclerosis. However, NAFLD and atherosclerosis have not been investigated simultaneously in animal models fed a high-cholesterol diet. Moreover, it is unclear whether systemic inflammation can exacerbate both pathologies in the same model. Accordingly, this study investigated the effect of additional systemic inflammation on NAFLD and atherosclerosis induced by cholesterol overload in wild animals. New Zealand white rabbits were divided into 4 groups: groups I (control) and II received normal chow, and groups III and IV received a 1% cholesterol diet. To induce inflammation via toll-like receptor (TLR)-4 signaling, groups II and IV received subcutaneous injections of 0.5 mL of 1% carrageenan every 3 weeks. After 3 months, total cholesterol markedly increased in groups III and IV, and the serum expressions of systemic inflammatory markers were elevated in the groups II–IV. Early NAFLD lesions (e.g., mild fatty changes in the liver with sporadic fibrosis) and atherosclerosis (e.g., intimal hyperplasia composed of foam cells) were observed in both the liver and aorta specimens from group III, and advanced lesions were observed in group IV. The expressions of inflammatory cellular receptors, TLR-2 and TLR-4, in the aorta gradually increased from group I to IV but were similar in the liver in groups II–IV. Cholesteryl ester (CE) levels were higher in group IV than in group III, although the difference was not significant. CE levels in the aorta were similar between groups III and IV. Systemic inflammation can simultaneously exacerbate existing early lesions due to cholesterol overload in both the liver and aorta of rabbits. However, the cellular response of inflammatory receptors and expression of cholesterol metabolites differ between these organs. Public Library of Science 2014-06-05 /pmc/articles/PMC4046981/ /pubmed/24901254 http://dx.doi.org/10.1371/journal.pone.0097841 Text en © 2014 Kim et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Kim, Eung Ju
Kim, Baek-hui
Seo, Hong Seog
Lee, Yong Jik
Kim, Hyun Hee
Son, Hyun-Hwa
Choi, Man Ho
Cholesterol-Induced Non-Alcoholic Fatty Liver Disease and Atherosclerosis Aggravated by Systemic Inflammation
title Cholesterol-Induced Non-Alcoholic Fatty Liver Disease and Atherosclerosis Aggravated by Systemic Inflammation
title_full Cholesterol-Induced Non-Alcoholic Fatty Liver Disease and Atherosclerosis Aggravated by Systemic Inflammation
title_fullStr Cholesterol-Induced Non-Alcoholic Fatty Liver Disease and Atherosclerosis Aggravated by Systemic Inflammation
title_full_unstemmed Cholesterol-Induced Non-Alcoholic Fatty Liver Disease and Atherosclerosis Aggravated by Systemic Inflammation
title_short Cholesterol-Induced Non-Alcoholic Fatty Liver Disease and Atherosclerosis Aggravated by Systemic Inflammation
title_sort cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046981/
https://www.ncbi.nlm.nih.gov/pubmed/24901254
http://dx.doi.org/10.1371/journal.pone.0097841
work_keys_str_mv AT kimeungju cholesterolinducednonalcoholicfattyliverdiseaseandatherosclerosisaggravatedbysystemicinflammation
AT kimbaekhui cholesterolinducednonalcoholicfattyliverdiseaseandatherosclerosisaggravatedbysystemicinflammation
AT seohongseog cholesterolinducednonalcoholicfattyliverdiseaseandatherosclerosisaggravatedbysystemicinflammation
AT leeyongjik cholesterolinducednonalcoholicfattyliverdiseaseandatherosclerosisaggravatedbysystemicinflammation
AT kimhyunhee cholesterolinducednonalcoholicfattyliverdiseaseandatherosclerosisaggravatedbysystemicinflammation
AT sonhyunhwa cholesterolinducednonalcoholicfattyliverdiseaseandatherosclerosisaggravatedbysystemicinflammation
AT choimanho cholesterolinducednonalcoholicfattyliverdiseaseandatherosclerosisaggravatedbysystemicinflammation